Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04466306 · ClinicalTrials.gov registry record
Pediatric Acute Kidney Injury in COVID-19
A clinical trial, sponsored by Children's Healthcare of Atlanta.
- Completed
- Registry status
- 400
- Enrollment target
NCT04466306: Completed study, sponsored by Children's Healthcare of Atlanta.
NCT04466306 is a clinical trial that has completed, run by Children's Healthcare of Atlanta. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04466306 has completed, sponsored by Children's Healthcare of Atlanta.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
This study is an observational registry of children with or suspected to have SARS CoV2 (COVID-19) admitted to pediatric intensive care units (PICU). This registry will help describe the prevalence, rate and severity of acute kidney injury (AKI) in children with Severe Acute Respiratory Syndrome Coronavirus-2(SARS CoV2) across the world. The registry will be developed using a point prevalence methodology and then full retrospective review. Once a week, from April through June 2020, data collection will occur in "real-time" to estimate a weekly point prevalence of AKI and renal replacement therapy (RRT). The operational definition of "patients under investigation" (PUIs) will be used to identify the denominator of patients to be studied. The PUIs will be cohorted into SARS CoV2 test positive, test negative, test pending, or test unavailable. The primary aim of this study is to deliver a global, objective data driven analysis of the burden of AKI in virus positive patients or patients under investigation (PUI) who are admitted to the pediatric intensive care unit.
Primary Outcome
Kidney Disease Improving Global Outcomes (KDIGO) Staged AKI by serum creatinine or urine output
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2020-04-15 |
| Est. Completion | 2021-07-01 |
What the finished NCT04466306 record still lists
NCT04466306 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04466306 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04466306 about?
NCT04466306 is a clinical study titled "Pediatric Acute Kidney Injury in COVID-19". This study is an observational registry of children with or suspected to have SARS CoV2 (COVID-19) admitted to pediatric intensive care units (PICU). This registry will help describe the prevalence, rate and severity of acute kidney injury (AKI) in children with Severe Acute Respiratory Syndrome Cor...
What is the current status of trial NCT04466306?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2020-04-15. Estimated completion is 2021-07-01.
Who is sponsoring clinical trial NCT04466306?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI